AMEDES acquired by OMERS
Context
A consortium led by Goldman Sachs Asset Management and OMERS Infrastructure acquired amedes from Antin Infrastructure Partners. The transaction valued roughly doubling its value since Antin's entry in 2015. The deal aims to support amedes' continued growth through digitalization and further consolidation of the European lab market.
In the past, Amedes underwent an LBO led by Antin Infrastructure in 2015.
AMEDES, which reported an EBITDA margin of [members only] in 2020, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Amedes is one of the leading platforms for medical diagnostics in Germany. It has 35 laboratories and 27 practices across Germany and Belgium.
Ent. Value
€1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
Above 6x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with AMEDES
Other operations with AMEDES
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2015 | ANTIN INFRASTRUCTURE | AMEDES | GERMANY | Labs (Biology) |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2021 | LIVINGBRIDGE | EVERLIGHT RADIOLOGY | UNITED KINGDOM | Radiology |
| 08/2021 | COLOSSEUM DENTAL GROUP | CURAEOS | NETHERLANDS | Dental Centers |
| 07/2021 | WREN HOUSE | ALMAVIVA SANTÉ | FRANCE | Clinics / Hospitals |
| 07/2021 | EQT PARTNERS | BLIKK GROUP | GERMANY | Radiology |
| 07/2021 | CERBA HEALTHCARE | LIFEBRAIN | ITALY | Labs (Biology) |
| 07/2021 | EQT PARTNERS | MEINE RADIOLOGIE | GERMANY | Radiology |
| 05/2021 | INFRATIL | PACIFIC RADIOLOGY GROUP | NEW ZEALAND | Radiology |
| 04/2021 | AMERICAN SECURITIES | SIMONMED IMAGING | UNITED STATES | Radiology |
| 04/2021 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
| 03/2021 | EQT PARTNERS | CERBA HEALTHCARE | FRANCE | Labs (Biology) |
Other operations with OMERS
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2021 | OMERS | INTERNATIONAL SCHOOLS PARTNERSHIP | UNITED KINGDOM | Education Providers |
| 11/2017 | OMERS | TRESCAL | FRANCE | TIC (Testing, Inspection, Certification) |
| 02/2016 | OMERS | Forefront Dermatology | UNITED STATES | Outpatient Care |
REFERENCES
Valuation range: EV €1–10bn
Revenue range: €100–200M
EV/Revenue range: Above 6x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of AMEDES by OMERS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: omers